PALOMA
Primary comparison of liposomal Anthracycline based treatment versus conventional care strategies before allogeneic stem cell transplantation in patients with higher risk MDS and oligoblastic AML – the PALOMA study
Studienleiter | Prof. Dr. med. Platzbecker |
---|---|
EudraCT-Nr. | 2018-002430-21 |
Studientyp | randomisiert, Phase II |
Indikation | MDS/AML |
ClinicalTrial | NCT04061239 |